CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 89 enrolled
Drug / intervention
Tranexamic Acid +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02253810
NCT02253810N/ACompleted
CompareCT.gov

The Effect of Intravenous Tranexamic Acid on Blood Loss and Transfusion After Periacetabular Osteotomy: a Prospective, Double-blinded, Randomized Controlled Trial

Hospital for Special Surgery, New York·interventional·Posted Oct 1, 2014·Updated Nov 25, 2022

In Brief

A clinical study evaluating Tranexamic Acid and Placebo for Dysplasia, Congenital Hip. Completed, enrolled 89 participants across 1 site.

Detailed Summary

The goal of this randomized controlled, double-blinded trial is to assess the efficacy of intravenous tranexamic acid, a drug, in reducing blood loss and transfusion in patients undergoing periacetabular osteotomy, an elective reorientation procedure for the hip joint. The investigators hypothesize that tranexamic acid will be more effective than placebo (normal saline solution) in reducing blood loss and transfusion after periacetabular osteotomy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDysplasia, Congenital Hip
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 1, 2014
Enrollment StartOct 1, 2014
Primary CompletionOct 1, 2018
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 11.8 years ago

Interventions

Tranexamic Aciddrug

Medication administered intra-operatively to promote blood clotting.

Placebodrug

Saline solution